Over time, excessive sun exposure can lead to dark spots, uneven skin tone, and dullness
Oral GLP-1 Tablets GLP-1 tablets that dissolve in the mouth for greater convenience
Also, small molecule PAMs of GLP-1 have been found that can potentiate the action of GLP-1 (7-36) and its metabolite GLP-1 (9-36), which retains some weak activity (EC 50 = 1.8 M, E MAX = 13%) for GLP-1R
Current US guidelines, including those from the US Preventive Services Task Force and American College of Gastroenterology, emphasize that new rectal bleeding in adults 45 and older requires investigation to exclude colorectal malignancy, regardless of presumed benign causes

Several factors may contribute to dizziness in patients taking GLP-1 medications: Hypoglycaemia (low blood glucose) particularly when GLP-1 agonists are used alongside other glucose-lowering medications such as sulphonylureas or insulin Dehydration resulting from reduced fluid intake due to decreased appetite or from gastrointestinal side effects such as nausea, vomiting, or diarrhoea Orthostatic hypotension a drop in blood pressure upon standing, which may occur due to volume depletion or rapid weight loss Reduced caloric intake significant appetite suppression may lead to inadequate nutrition, potentially causing weakness and dizziness The frequency and severity of dizziness vary between individuals and specific GLP-1 products